According to the current analysis of Reports and Data, the global Nephrology And Urology Devices Market valued at USD 831.8 million in 2018 and is expected to reach USD 1.51 billion by the year 2026 at a CAGR of 7.7%. Nephrostomy devices are used in treating the blocked ureters of the kidney and also to restore the urine flow from blocked ureters for better functioning of the organ. Blocked ureters cause a rise in the pressure in the kidneys that causes further damage to kidneys such as hydronephrosis. It is caused due to the blocked ureters. Ideally, nephrostomy catheters are used for the treatment. Rise incidences of hydronephrosis are expected to boost for nephrostomy devices market. However, the increase in the geriatric population, ovarian, and prostate cancers are expected to fuel the market in the forecast period. Nephrostomy is regarded as a first-line treatment for patients suffering from kidney stones larger than 2 cm. However, high expenditure of therapy, alternative substitutes for nephrostomy, and the procedure being slightly painful these factors are likely to restrain the market growth.
The Asia Pacific region had marked a significant growth in the market due to the rise in the better reimbursement policies, better healthcare facilities, increased funding by the government for RD activities in surgical devices and procedures.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @https://www.reportsanddata.com/sample-enquiry-form/2712
Further key findings from the report suggest
- In 2016 the Biotherapy Researchers and Researchers of Rutgers Cancer Institute of New Jersey had conducted a study to evaluate the safe use of Nephrostomy Tube for Delivering chemotherapy. During the study, a nephrostomy tube was temporarily inserted into the patient’s body, and after surgery, the patient received either chemotherapy or biotherapy, like Bacillus Calmette–Guérin was directly given to the kidney for killing the tumor cells.
- ConvertX has modernized the procedure for nephrostomy earlier; a catheter was placed to drain urine into a bag, and then after few days, the catheter was, and then a stent was placed, but ConvertX was designed to have the stent delivered during catheter placement and is expanded after drainage is complete. The catheter transforms into a stent quickly without the need for fluoroscopy or sedating the patient the stent functions like other existing ureteral stents
- Cook Medical had launched Ultraxx Nephrostomy Balloon Catheter. It was used to dilate the musculofascia, renal capsule, and parenchyma and to maintain a percutaneous nephrostomy tract. Radiopaque markers were used that indicate the proximal and the distal end of the balloon. The balloon is designed with the burst pressure of 20 atm.
- Boston Scientific Corporation, in the year 2018, had launched LithoVue Empower Retrieval Deployment Device globally; it was designed to be used with the LithoVue.I t is a Single-Use Digital Flexible Ureteroscope that also contains a compatible nitinol retrieval basket that enables the urologists to operate a ureteroscope and basket simultaneously while retrieving kidney stones via flexible ureteroscopy.
- Drainage tube have held a significant market share of about 21.8% in the year 2018 as these tubes are essential in draining out the urine from the body the is likely to grow in the forecast period owing to the rise in the kidney related disorders globally.
- Specialty clinics in the end use segment are likely to rise with a significant market share due to the rise in the incidences of kidney stones, kidney-related problems, hydronephrosis, and kidney failure, etc. it is likely to grow with a CAGR of 7.7% in the forecast period.
- Cardinal Health had launched urology products like intermittent catheters; it is a latex-free catheter and includes the selection of Rob-Nel, Robinson, female, and pediatric catheters.
- key participants include Boston Scientific Corp (U.S.), Teleflex, Inc. (U.S.), Cardinal Health (U.S.), Becton, Dickinson and Company (U.S.), Cook Medical (U.S.), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark), Olympus Corp (Japan), Argon Medical (U.S.), and Uresil LLC (U.S.), are the key players of the Nephrostomy Devices market.Boston Scientific Corp (U.S.), Teleflex, Inc. (U.S.), Cardinal Health (U.S.), Becton, Dickinson and Company (U.S.), Cook Medical (U.S.), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark), Olympus Corp (Japan), Argon Medical (U.S.), and Uresil LLC (U.S.)
Browse Full Report Description + Research Methodology + Table of Content + Infographics @ https://www.reportsanddata.com/report-detail/nephrostomy-devices-market
For the purpose of this report, Reports and Data has segmented the Nephrostomy Devices market on the basis of Products, end use and region:
Products Outlook (Revenue in Million USD; 2016–2026)
- Guidewires
- Drainage Tubes
- Nephrostomy Catheters
- Sheath Dilators
- Others
End use (Revenue in Million USD; 2016–2026)
- Hospitals
- Emergency Clinics
- Ambulatory Surgical Centers (ASCs)
- Specialty Clinics
Regional Outlook (Revenue in Million USD; 2016–2026)
- North America
- U.S
- Canada
- Europe
- Germany
- France
- U.K
- Spain
- Italy
- Rest of the Europe
- Asia Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
- Middle East Africa
- Latin America
- Brazil
The pharma and healthcare industry is expected to observe significant growth over the coming years attributed to the increasing incidence of chronic diseases across the globe, growing geriatric patient pool, availability of advanced and minimally invasive surgical and diagnostics procedures, favorable reimbursement scenario, and presence of a robust product pipeline of drugs and therapeutics. In addition, growing integration of IoT, ML, and AI in medical procedures and equipment along with rapid progress in drug design and development. Combination of innovation and technology has brought about massive changes in the healthcare industry and the rapid adoption of telemedicine, remote consultation, and e-prescription have significantly contributed to the revenue growth of the market.
Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register highest market growth over the forecast period attributed to increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.
Request a customization on the report @https://www.reportsanddata.com/request-customization-form/2712
Growing popularity of over-the-counter medications driving market growth
Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.
Restriction on product launches and RD activities to hamper market growth
Imposition of strict government regulations and shortage of funds have put a halt on the product launches and RD activities and are expected to restrain market growth over the forecast period. In addition, launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering market growth.
Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/video
